CervoMed Inc — Dividend History & Yield (NASDAQ:CRVO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

News

CervoMed’s neflamapimod selected for UK ALS trial platform

Cantor Fitzgerald initiates CervoMed stock with Overweight rating

CervoMed’s DLB drug shows promise in phase 2b trial

CervoMed stock soars after promising dementia drug trial results

Neflamapimod reduces key neurodegeneration markers in DLB study

CervoMed Inc. (CRVO) Reports Q3 Loss, Misses Revenue Estimates

Atara Biotherapeutics (ATRA) Surges 10.0%: Is This an Indication of Further Gains?

Lexicon Pharmaceuticals (LXRX) Reports Q3 Loss, Beats Revenue Estimates

This Sarepta Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - Boise Cascade (NYSE:BCC), CervoMed (NASDAQ:CRVO)

CervoMed stock rises after FDA alignment on Phase 3 trial design

FDA aligns with CervoMed on phase 3 trial design for DLB treatment

CervoMed appoints McKinsey veteran David Quigley to board of directors